Overview Request Sample Pages Request Customization Download PDF
You are viewing: US Periodontal Disease Treatment Market analysis

The US Periodontal Disease Treatment Market was valued at $299.84 Million in 2024 and projected to reach to $412.07 Million by 2029, representing a compound annual growth rate of 5.4%. The US periodontal disease treatment market is positioned for sustained growth through 2029, supported by demographic shifts, aging populations with higher disease incidence, and expanding insurance coverage for periodontal interventions.

US Periodontal Disease Treatment Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Periodontal Disease Treatment Market Trends and Insights

  • The US market is driven by rising prevalence of periodontal disease, increasing awareness of oral health, and growing adoption of advanced treatment technologies among US dental practitioners.
  • In the US, both preventive and therapeutic interventions are gaining traction as patients and providers recognize the link between periodontal health and systemic disease outcomes. The US periodontal treatment landscape encompasses scaling and root planing, surgical interventions, antimicrobial therapies, and regenerative procedures.
  • The US market benefits from strong healthcare infrastructure, high dental insurance penetration, and robust reimbursement frameworks that support patient access to specialized periodontal care.
  • Over the forecast period through 2029, the US is expected to see continued investment in minimally invasive techniques and digital diagnostic tools that enhance treatment precision and patient outcomes..

Key Market Statistics

  • CAGR (2024-2029) 5.4% CAGR
  • Market Size, 2024 ~USD 299.84 Million
  • Forecast, 2029 ~USD 412.07 Million
  • Country US

US Periodontal Disease Treatment Market Overview

Market Size & Growth :

The US periodontal disease treatment market reached $299.84 million in 2024 and is expected to grow to $412.07 million by 2029, representing a steady 5.4% CAGR driven by increasing disease prevalence and treatment adoption.

Rising Disease Prevalence :

Growing prevalence of periodontal disease among US adults, coupled with increased awareness of oral health consequences, is driving demand for professional treatment solutions and preventive care interventions across dental practices.

Technology Adoption :

US dental practitioners are increasingly adopting advanced treatment technologies including laser therapy, regenerative procedures, and minimally invasive techniques, enhancing treatment efficacy and patient outcomes in the periodontal segment.

Market Maturity :

The US represents a mature, well-established market with strong healthcare infrastructure, high insurance coverage for dental procedures, and significant investment in dental innovation and clinical research.

US Periodontal Disease Treatment Market Dynamics

  • Increasing consumer awareness campaigns and preventive care initiatives are driving patient engagement and early diagnosis rates.
  • The market will benefit from continuous technological advancements in treatment modalities and growing integration of digital diagnostics in US dental practices.
  • Healthcare providers are investing in specialized periodontal services to capture growing demand segments..

Related Ecosystem

Dental Devices

Top Technologies
  • Dental Implants
  • Dental Bone Grafts
  • Dental Crowns
  • Dental Prosthetics
  • Zirconium Implants
Top Companies
  • DENTSPLY SIRONA Inc.
  • Henry Schein, Inc.
  • KAVO KERR GROUP
  • PLANMECA GROUP
  • Patterson Companies, Inc.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • CONMED Corporation

      Key Takeaways

      • The US periodontal disease treatment market is valued at $299.84 million in 2024 and will reach $412.07 million by 2029 at a 5.4% CAGR.
      • The US market is supported by high dental insurance coverage, advanced healthcare infrastructure, and strong reimbursement policies that facilitate patient access to periodontal care.
      • Rising prevalence of periodontal disease and increased patient awareness of oral-systemic health connections are key growth drivers in the US market.
      • The US periodontal treatment sector is experiencing adoption of minimally invasive techniques, digital diagnostics, and regenerative therapies that improve clinical outcomes.

      Periodontal Disease Treatment Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment AGGRESSIVE PERIODONTITIS (Disease)
      Forecast Period 2024–2029
      Growth Rate CAGR of 5.9% from 2024 to 2029
      Largest Segment NON-SURGICAL TREATMENT (Treatment)
      Market Size Base Year (Billions) ~USD 2.57 (2024)
      Revenue Forecast (Billions) ~USD 3.43 (2029)
      Segments Covered Product, Disease, Type, Treatment

      US Periodontal Disease Treatment Market Report Segmentation

      4 segment dimensions are covered across the global market.

      By Product

      • Consumables
      • Equipment
      • Medication

      By Disease

      • Aggressive Periodontitis
      • Chronic Periodontitis
      • Gingivitis
      • Other Diseases

      By Type

      • Acute Gingivitis
      • Chronic Gingivitis
      • Medication Therapy
      • Recurrent Gingivitis
      • Root Planing
      • Scaling

      By Treatment

      • Bone Grafting
      • Flap Surgery/Pocket Reduction Therapy
      • Guided Tissue Regeneration
      • Non-Surgical Treatment
      • Other Treatments
      • Soft Tissue Graft

      Target Audience

      • Dental Device Manufacturers : Manufacturers of periodontal treatment devices and equipment need US-specific market data to assess market potential, identify growth segments, plan product launches, and optimize distribution strategies in this $412M opportunity.
      • Pharmaceutical Companies : Pharma firms developing periodontal therapeutics require detailed US market insights to understand treatment adoption rates, competitive positioning, reimbursement scenarios, and clinical practice patterns for market penetration.
      • Dental Practice Groups & Clinics : Dental practitioners and practice management organizations need market intelligence to justify investment in periodontal services, understand patient demand trends, and benchmark their service offerings against market growth.
      • Healthcare Investors & PE Firms : Investment firms evaluating dental healthcare opportunities require comprehensive US market data to assess valuation multiples, growth potential, exit opportunities, and risk factors in the periodontal treatment segment.
      • Healthcare Consultants & Analysts : Consulting firms and research analysts advising healthcare clients need authoritative US market data to support strategic recommendations, validate business cases, and provide evidence-based insights to stakeholders.

      Key Companies in the US Periodontal Disease Treatment Market

      CompanyHQOwnershipStrongest segments
      DENTSPLY SIRONAUnited StatesPublic CompanyConnected Technology Solutions,Essential Dental Solutions,Orthodontic and Implant Solutions,
      ENVISTA HOLDINGS CORPORATIONUnited StatesPublic CompanySpecialty Products & Technologies – Implants & Biomaterials,Specialty Products & Technologies – Orthodontics & Clear Aligners,Equipment & Consumables – Imaging, Software & Visualization,
      HENRY SCHEIN, INC.United StatesPublic CompanyGlobal Distribution and Value-Added Services,Global Specialty Products,Global Technology,
      BIOLASE, INC.United StatesPublic CompanyWaterlase all-tissue systems,Diode soft-tissue systems,Consumables, fibers, and handpieces,
      NAKANISHI INC.JapanPublic CompanyDental handpieces (air turbines, contra-angles, micromotors),Surgical and mobile dentistry systems,Dental lab, hygiene, and maintenance products,
      A-DEC INC.SwitzerlandPublic CompanyFlexible placement (temporary staffing and contracting),Permanent placement and career transition,Outsourcing and engineering consulting,

      DENTSPLY SIRONA

      DENTSPLY SIRONA is a United States-based public company founded in 1877 with 14,000 employees. The company operates in the dental industry.

      ENVISTA HOLDINGS CORPORATION

      ENVISTA HOLDINGS CORPORATION is a United States-based public company founded in 2018 with 12,000 employees. The company operates in the dental industry.

      HENRY SCHEIN, INC.

      HENRY SCHEIN, INC. is a United States-based public company founded in 1932 with 25,000 employees. The company operates in the dental industry.

      BIOLASE, INC.

      BIOLASE, INC. is a United States-based public company founded in 1984 with 157 employees. The company operates in the dental industry.

      NAKANISHI INC.

      NAKANISHI INC. is a Japan-based public company founded in 1930 with 2,204 employees. The company operates in the dental industry.

      A-DEC INC.

      A-DEC INC. is a Switzerland-based public company founded in 1957 with 33,569 employees. The company operates in the dental industry.

      Reasons to Buy this Report

      • Precise US Market Sizing : Access validated market size data specific to the United States ($299.84M in 2024) with accurate 5-year forecasts, enabling precise budget allocation and revenue projections for US-focused business strategies.
      • Competitive Landscape Intelligence : Understand the competitive dynamics within the US periodontal market, identify key players, market share distribution, and strategic positioning to inform competitive strategy and partnership opportunities.
      • Growth Driver Analysis : Detailed insights into US-specific growth catalysts including disease prevalence trends, insurance coverage expansion, technology adoption rates, and consumer awareness patterns driving the 5.4% CAGR.
      • Investment & Expansion Planning : Make informed decisions on market entry, facility expansion, or product launches in the US market with comprehensive data on regional demand, reimbursement landscapes, and regulatory requirements.
      • Strategic Benchmarking : Compare US market performance against global trends (5.9% global CAGR) to identify growth opportunities, market gaps, and areas where the US market outperforms or underperforms international benchmarks.

      Frequently asked questions

      What is the current size of the US periodontal disease treatment market?

      The US periodontal disease treatment market was valued at $299.84 million in 2024 and is expected to grow to $412.07 million by 2029.

      What is the projected growth rate for the US periodontal treatment market?

      The US periodontal disease treatment market is projected to grow at a compound annual growth rate (CAGR) of 5.4% from 2024 to 2029.

      What factors are driving growth in the US periodontal disease treatment market?

      Key drivers in the US market include rising periodontal disease prevalence, increased patient awareness of oral health, strong dental insurance coverage, and adoption of advanced treatment technologies.

      What treatment modalities are included in the US periodontal disease treatment market?

      The US market encompasses scaling and root planing, surgical interventions, antimicrobial therapies, regenerative procedures, and digital diagnostic tools.

      How does the US market compare to global periodontal treatment trends?

      The US market grows at 5.4% CAGR, slightly below the global rate of 5.9%, reflecting mature market dynamics and high baseline penetration of periodontal care services.

      RESEARCH METHODOLOGY

      Get the Full Periodontal Disease Treatment Market Report

      Full forecast, segment splits, and company analysis for all Periodontal Disease Treatment Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status